Oncotype DX Recurrence Score Impacts Breast Cancer Treatment Recommendations
20:01 EDT 12 Jul 2012 | Cancer Connect
Oncotype DX Recurrence Score results significantly impact treatment recommendations in estrogen receptor-positive early-stage breast cancer with no lymph node involvement, according to the results of a study presented at the 2012 annual meeting of th..
Original Article: Oncotype DX Recurrence Score Impacts Breast Cancer Treatment Recommendations
More From BioPortfolio on "Oncotype DX Recurrence Score Impacts Breast Cancer Treatment Recommendations"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
